Appraisal of the pediatric ulcerative colitis activity index (PUCAI)

Background: We evaluated the psychometric performance of the Pediatric Ulcerative Colitis Activity Index (PUCAI) in a real‐life cohort from the Pediatric IBD Collaborative Research Group. Methods: Two consecutive visits of 215 children with ulcerative colitis (UC) were included (mean age 11.2 ± 3.6 years; 112 (52%) males; 63 (29%) newly diagnosed and the others after disease duration of 24 ± 15.6 months). Validity was assessed using several constructs of disease activity. Distributional and anchor‐based strategies were used to assess the responsiveness of the PUCAI to change over time following treatment. Results: Reflecting feasibility, 97.6% of 770 eligible registry visits had a completed PUCAI score versus only 47.6% for a contemporaneously collected Pediatric Crohn's Disease Activity Index (odds ratio = 45.8, 95% confidence interval [CI] 28.6–73.5) obtained for children with Crohn's disease accessioned into the same database. The PUCAI score was significantly higher in patients requiring escalation of medical therapy (45 points [interquartile range, IQR, 30–60]) versus those who did not, (0 points [IQR 0–10]; P < 0.001), and was highly correlated with physician's global assessment of disease activity (r = 0.9, P < 0.001). The best cutoff to differentiate remission from active disease was 10 points (area under receiver operating characteristic curve [AUC] 0.94; 95% CI 0.90–0.97). Test–retest reliability was excellent (intraclass correlation coefficient = 0.89; 95% CI 0.84–0.92, P < 0.001) as well as responsiveness to change (AUC 0.96 [0.92–0.99]; standardized response mean 2.66). Conclusion: This study on real‐life, prospectively obtained data confirms that the PUCAI is highly feasible by virtue of the noninvasiveness, valid, and responsive index. The PUCAI can be used as a primary outcome measure to reflect disease activity in pediatric UC. (Inflamm Bowel Dis 2009)

[1]  D. Streiner,et al.  Health measurement scales , 2008 .

[2]  A. Griffiths,et al.  Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy , 2007, Gut.

[3]  A. Griffiths,et al.  Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. , 2007, Gastroenterology.

[4]  A. Griffiths,et al.  Laboratory Values for Children With Newly Diagnosed Inflammatory Bowel Disease , 2007, Pediatrics.

[5]  Philippe Marteau,et al.  A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. , 2007, Gastroenterology.

[6]  W. Tierney,et al.  Measuring Patient and Clinician Perspectives to Evaluate Change in Health-Related Quality of Life Among Patients with Chronic Obstructive Pulmonary Disease , 2007, Journal of General Internal Medicine.

[7]  D. Teitelbaum,et al.  Colostomy: formation and closure , 2006 .

[8]  J. Satsangi,et al.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[9]  G. Guyatt,et al.  Measurement Properties and Interpretability of the Chronic Respiratory Disease Questionnaire (CRQ) , 2005, COPD.

[10]  Ross D Crosby,et al.  Defining clinically meaningful change in health-related quality of life. , 2003, Journal of clinical epidemiology.

[11]  G. Norman,et al.  Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.

[12]  A. Griffiths,et al.  Pediatric Crohn Disease Activity Index: Responsive to Short-term Change , 2003, Journal of pediatric gastroenterology and nutrition.

[13]  G. Guyatt,et al.  A critical look at transition ratings. , 2002, Journal of clinical epidemiology.

[14]  D. Cella,et al.  Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening , 2002, Quality of Life Research.

[15]  D. Beaton,et al.  Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. , 2002, Current opinion in rheumatology.

[16]  K. Bruynesteyn,et al.  Robustness and generalizability of smallest detectable difference in radiological progression. , 2001, The Journal of rheumatology.

[17]  M. Lassere,et al.  Foundations of the minimal clinically important difference for imaging. , 2001, The Journal of rheumatology.

[18]  D. Beaton,et al.  Understanding the relevance of measured change through studies of responsiveness. , 2000, Spine.

[19]  W. Tierney,et al.  Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. , 1999, Journal of clinical epidemiology.

[20]  N. Jacobson,et al.  Methods for defining and determining the clinical significance of treatment effects: description, application, and alternatives. , 1999, Journal of consulting and clinical psychology.

[21]  W M Tierney,et al.  Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. , 1999, Medical care.

[22]  G. Regehr,et al.  Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach. , 1997, Journal of clinical epidemiology.

[23]  D L Riddle,et al.  Health status measures: strategies and analytic methods for assessing change scores. , 1996, Physical therapy.

[24]  C Jenkinson,et al.  Development Standards for Health Measures , 1996, Journal of health services research & policy.

[25]  R. Devellis.  A consumer's guide to finding, evaluating, and reporting on measurement instruments. , 1996, Arthritis care and research : the official journal of the Arthritis Health Professions Association.

[26]  J. Walker-Smith,et al.  Endoscopic assessment of the colonic response to corticosteroids in children with ulcerative colitis. , 1996, Journal of pediatric gastroenterology and nutrition.

[27]  J T Boyle,et al.  Development and validation of a pediatric Crohn's disease activity index. , 1991, Journal of pediatric gastroenterology and nutrition.

[28]  N. Jacobson,et al.  Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. , 1991, Journal of consulting and clinical psychology.

[29]  M. Liang,et al.  Comparisons of Five Health Status Instruments for Orthopedic Evaluation , 1990, Medical care.

[30]  G. Guyatt,et al.  Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.

[31]  J. Fleiss,et al.  Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.

[32]  F Kern,et al.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. , 1976, Gastroenterology.

[33]  G. Guyatt,et al.  The minimal detectable change cannot reliably replace the minimal important difference. , 2010, Journal of clinical epidemiology.

[34]  G. Guyatt,et al.  Measuring change over time: assessing the usefulness of evaluative instruments. , 1987, Journal of chronic diseases.

[35]  R A Deyo,et al.  Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance. , 1986, Journal of chronic diseases.